Line of Treatment
In this section you will find Therapeutics Line of Treatment market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
9 Item(s)
per page
-
Analytical Tool - Angiogenesis in Oncology
€3,100.00Published by BioSeeker Group on Feb 21st, 2012The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More -
Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2012
€1,499.00Published by BioSeeker Group on Feb 21st, 2012BioSeeker Group have identified 246 companies plus partners who are today developing 462 PKI drugs in 1514 developmental projects in cancer across 188 different targets. In addition, there are 8 suspended drugs and another 229 drugs where development has been ceased. Learn More -
The World Antibacterial Treatments Market 2010-2024
€1,739.00Published by Visiongain on Dec 2nd, 2009Over 130 tables, charts, graphs, figures included. Our latest report examines the prospects for antibacterial treatments worldwide from 2009 to 2024, including detailed sales forecasts for leading products in that... Learn More -
Pharmacovigilance Report and Analysis 2009: Present Challenges and Future Goals
€1,739.00Published by Visiongain on Apr 21st, 2009Pharmacovigilance has been expanding in recent years, as companies are required to monitor drug safety post launch. Where is pharmacovigilance heading? What regulatory measures will continue, and which new processes will emerge? Learn More -
Stem Cell Therapeutics Markets
€1,922.00Published by Kalorama Information on Feb 1st, 2009Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S... Learn More -
Strategic Outlook on Protein Kinase Inhibitors in Oncology
€1,950.00Published by BioSeeker Group on Feb 20th, 2006A strategic outlook on protein kinase inhibitors in oncology. Including targets, indictions and competitive assessment. Learn More -
New Concepts in Cancer Therapeutics
€2,450.00Published by BioSeeker Group on Dec 30th, 2005There are, at present, ten times more anticancer drugs being tested in clinical trials than there were 20 years ago. Many of the new classes of agents.... Learn More -
Apoptosis: Promise or deception?
€1,950.00Published by BioSeeker Group on May 7th, 2005In this publication, BioSeeker Group analyzes the latest progress made for 25 drug candidates targeting the cell death pathway, apoptosis. Additionally, more early stage candidates are also under investigation, which brings the total number of companies interested in this field to around 40. Learn More -
Vascular Targeting Agents: Emerging Competitors
€1,950.00Published by BioSeeker Group on Feb 8th, 2005An update on the most recent advances made for vascular targeting agents that are now entering an exciting stage of development. Learn More
9 Item(s)
per page